Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management

John Donald Marra, Filippo Frioni, Gessica Minnella, Monica Rossi, Tanja Malara, Silvia Bellesi, Elena Maiolo, Daniela Orteschi, Eugenio Galli, Andrea Bacigalupo, Livio Pagano, Simona Sica, Gina Zini Tanzi, Patrizia Chiusolo

Research output: Contribution to journalArticle

Abstract

A 70-year-old female patient with no known medical history presented in our ER with irradiating lumbar pain. CBC revealed moderate leukocytosis (WBC 25,000/mm3), severe thrombocytopenia (16,000/mm3), and moderate anemia (9.5 g/dL). Bone marrow (BM) aspirate (Fig. 1) revealed an infiltrate of blasts negative for myeloperoxidase (MPO) representing 65% of BM cellularity and trilineage dysplasia, compatible with a morphologic diagnosis of acute erythroid leukemia (AEL). Urgent molecular assays were positive for BCR/ABL1. The patient’s clinical conditions rapidly deteriorated, and despite maximal broad-spectrum antibiotics and vasopressors, the patient later succumbed to urosepsis in the ICU.
Original languageEnglish
Pages (from-to)N/A-N/A
JournalAnnals of Hematology
Volume103
DOIs
Publication statusPublished - 2024

Keywords

  • Classification
  • BCR-ABL
  • TP53
  • Acute erythroid leukemia

Fingerprint

Dive into the research topics of 'Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management'. Together they form a unique fingerprint.

Cite this